Nineties rapper, and the first lady of No Limit Records, Mia X, has earned a honorary doctorate and is now called Dr. Mia X ...

A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a $1.25 billion settlement as well as royalties on sales of one of its top HIV products.

When ViiV Healthcare and Johnson & Johnson launched their once-monthly injectable HIV treatment Cabenuva in 2021, they predicted that patients would prefer that option to the need to take tablets ...

This story is part of CBC Health's Second Opinion, a weekly analysis of health and medical science news emailed to subscribers on Saturday mornings. If you haven't subscribed yet, you can do that ...

At about the same time, generic versions of ViiV’s six-times-yearly PrEP drug cabotegravir should be coming online too, due to agreements signed with three generic companies. Encouraged by these ...

POTOMAC, MD / ACCESS Newswire / March 20, 2025 / IGC Pharma, Inc. (“IGC”, or the “Company”) (NYSE American:IGC) today announced the expansion of its ongoing Phase 2 CALMA trial for IGC-AD1 with the ...

Development of both the prostate cancer androgen receptor assay and the multi-cancer DDR micronuclei assay successfully completed for AstraZeneca Results of Eisai Phase 2 pilot study supports the ...